Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Cellular and Extracellular Matrix of bone, with Principals of Synthesis and Dependency of Mineral Deposition on Cell Membrane Transport.

Schlesinger PH, Blair HC, Beer Stolz D, Riazanski V, Ray EC, Tourkova IL, Nelson DJ.

Am J Physiol Cell Physiol. 2019 Sep 18. doi: 10.1152/ajpcell.00120.2019. [Epub ahead of print]

PMID:
31532718
2.

The high-density lipoprotein receptor Scarb1 is required for normal bone differentiation in vivo and in vitro.

Tourkova IL, Dobrowolski SF, Secunda C, Zaidi M, Papadimitriou-Olivgeri I, Papachristiou DJ, Blair HC.

Lab Invest. 2019 Dec;99(12):1850-1860. doi: 10.1038/s41374-019-0311-0. Epub 2019 Aug 29.

PMID:
31467425
3.

Absence of Dipeptidyl Peptidase 3 Increases Oxidative Stress and Causes Bone Loss.

Menale C, Robinson LJ, Palagano E, Rigoni R, Erreni M, Almarza AJ, Strina D, Mantero S, Lizier M, Forlino A, Besio R, Monari M, Vezzoni P, Cassani B, Blair HC, Villa A, Sobacchi C.

J Bone Miner Res. 2019 Nov;34(11):2133-2148. doi: 10.1002/jbmr.3829. Epub 2019 Sep 9.

PMID:
31295380
4.

The roles of Orai and Stim in bone health and disease.

Robinson LJ, Blair HC, Barnett JB, Soboloff J.

Cell Calcium. 2019 Jul;81:51-58. doi: 10.1016/j.ceca.2019.06.001. Epub 2019 Jun 5. Review.

PMID:
31201955
5.

Western-type diet differentially modulates osteoblast, osteoclast, and lipoblast differentiation and activation in a background of APOE deficiency.

Papachristou NI, Blair HC, Kalyvioti ES, Syggelos SA, Karavia EA, Kontogeorgakos V, Nikitovic D, Tzanakakis GN, Kypreos KE, Papachristou DJ.

Lab Invest. 2018 Dec;98(12):1516-1526. doi: 10.1038/s41374-018-0107-7. Epub 2018 Sep 11.

6.

A bone mineralization defect in the Pahenu2 model of classical phenylketonuria involves compromised mesenchymal stem cell differentiation.

Dobrowolski SF, Tourkova IL, Robinson LJ, Secunda C, Spridik K, Blair HC.

Mol Genet Metab. 2018 Nov;125(3):193-199. doi: 10.1016/j.ymgme.2018.08.010. Epub 2018 Aug 27.

7.

Sphingosine-1-Phosphate Modulates the Effect of Estrogen in Human Osteoblasts.

Tantikanlayaporn D, Tourkova IL, Larrouture Q, Luo J, Piyachaturawat P, Witt MR, Blair HC, Robinson LJ.

JBMR Plus. 2018 Jul;2(4):217-226. doi: 10.1002/jbm4.10037. Epub 2018 Jan 29.

8.

Support of bone mineral deposition by regulation of pH.

Blair HC, Larrouture QC, Tourkova IL, Liu L, Bian JH, Stolz DB, Nelson DJ, Schlesinger PH.

Am J Physiol Cell Physiol. 2018 Oct 1;315(4):C587-C597. doi: 10.1152/ajpcell.00056.2018. Epub 2018 Jul 25.

9.

Actions of pituitary hormones beyond traditional targets.

Zaidi M, New MI, Blair HC, Zallone A, Baliram R, Davies TF, Cardozo C, Iqbal J, Sun L, Rosen CJ, Yuen T.

J Endocrinol. 2018 Jun;237(3):R83-R98. doi: 10.1530/JOE-17-0680. Epub 2018 Mar 19. Review.

10.

Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital.

Wheeler SE, Liu L, Blair HC, Sivak R, Longo N, Tischler J, Mulvey K, Palmer OMP.

BMC Res Notes. 2017 Dec 8;10(1):725. doi: 10.1186/s13104-017-3050-6.

11.

Adrenocorticotropic hormone and 1,25-dihydroxyvitamin D3 enhance human osteogenesis in vitro by synergistically accelerating the expression of bone-specific genes.

Tourkova IL, Liu L, Sutjarit N, Larrouture QC, Luo J, Robinson LJ, Blair HC.

Lab Invest. 2017 Sep;97(9):1072-1083. doi: 10.1038/labinvest.2017.62. Epub 2017 Jul 24.

12.

High-density lipoprotein (HDL) metabolism and bone mass.

Papachristou NI, Blair HC, Kypreos KE, Papachristou DJ.

J Endocrinol. 2017 May;233(2):R95-R107. doi: 10.1530/JOE-16-0657. Epub 2017 Mar 17. Review.

13.

Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro.

Blair HC, Larrouture QC, Li Y, Lin H, Beer-Stoltz D, Liu L, Tuan RS, Robinson LJ, Schlesinger PH, Nelson DJ.

Tissue Eng Part B Rev. 2017 Jun;23(3):268-280. doi: 10.1089/ten.TEB.2016.0454. Epub 2016 Dec 27.

14.

Beyond Reproduction: Pituitary Hormone Actions on Bone.

Yuen T, Sun L, Liu P, Blair HC, New M, Zallone A, Zaidi M.

Prog Mol Biol Transl Sci. 2016;143:175-185. doi: 10.1016/bs.pmbts.2016.08.004. Epub 2016 Sep 7. Review.

PMID:
27697202
15.

Apolipoprotein A-1 regulates osteoblast and lipoblast precursor cells in mice.

Blair HC, Kalyvioti E, Papachristou NI, Tourkova IL, Syggelos SA, Deligianni D, Orkoula MG, Kontoyannis CG, Karavia EA, Kypreos KE, Papachristou DJ.

Lab Invest. 2016 Jul;96(7):763-72. doi: 10.1038/labinvest.2016.51. Epub 2016 Apr 18.

16.

Bone and high-density lipoprotein: The beginning of a beautiful friendship.

Papachristou DJ, Blair HC.

World J Orthop. 2016 Feb 18;7(2):74-7. doi: 10.5312/wjo.v7.i2.74. eCollection 2016 Feb 18.

17.

Suppression of arthritis-induced bone erosion by a CRAC channel antagonist.

Blair HC, Soboloff J, Robinson LJ, Tourkova IL, Larrouture QC, Witt MR, Holaskova I, Schafer R, Elliott M, Hirsch R, Barnett JB.

RMD Open. 2016 Jan 8;2(1):e000093. doi: 10.1136/rmdopen-2015-000093. eCollection 2016.

18.

Chloride-hydrogen antiporters ClC-3 and ClC-5 drive osteoblast mineralization and regulate fine-structure bone patterning in vitro.

Larrouture QC, Nelson DJ, Robinson LJ, Liu L, Tourkova I, Schlesinger PH, Blair HC.

Physiol Rep. 2015 Nov;3(11). pii: e12607. doi: 10.14814/phy2.12607. Epub 2015 Nov 24.

19.

Nature and nurture in atherosclerosis: The roles of acylcarnitine and cell membrane-fatty acid intermediates.

Blair HC, Sepulveda J, Papachristou DJ.

Vascul Pharmacol. 2016 Mar;78:17-23. doi: 10.1016/j.vph.2015.06.012. Epub 2015 Jun 30. Review.

20.

The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.

Yang Y, Blair HC, Shapiro IM, Wang B.

J Biol Chem. 2015 Jul 3;290(27):16918-28. doi: 10.1074/jbc.M115.663963. Epub 2015 May 15.

21.

Buried in the Middle but Guilty: Intronic Mutations in the TCIRG1 Gene Cause Human Autosomal Recessive Osteopetrosis.

Palagano E, Blair HC, Pangrazio A, Tourkova I, Strina D, Angius A, Cuccuru G, Oppo M, Uva P, Van Hul W, Boudin E, Superti-Furga A, Faletra F, Nocerino A, Ferrari MC, Grappiolo G, Monari M, Montanelli A, Vezzoni P, Villa A, Sobacchi C.

J Bone Miner Res. 2015 Oct;30(10):1814-21. doi: 10.1002/jbmr.2517. Epub 2015 May 21.

22.

Elaidate, an 18-carbon trans-monoenoic fatty acid, but not physiological fatty acids increases intracellular Zn(2+) in human macrophages.

Zacherl JR, Tourkova I, St Croix CM, Robinson LJ, Peck Palmer OM, Mihalik SJ, Blair HC.

J Cell Biochem. 2015 Apr;116(4):524-32. doi: 10.1002/jcb.25002.

23.

Follicle stimulating hormone receptor in mesenchymal stem cells integrates effects of glycoprotein reproductive hormones.

Tourkova IL, Witt MR, Li L, Larrouture Q, Liu L, Luo J, Robinson LJ, Blair HC.

Ann N Y Acad Sci. 2015 Jan;1335:100-9. doi: 10.1111/nyas.12502. Epub 2014 Aug 12.

24.

Follistatin-like protein 1 regulates chondrocyte proliferation and chondrogenic differentiation of mesenchymal stem cells.

Chaly Y, Blair HC, Smith SM, Bushnell DS, Marinov AD, Campfield BT, Hirsch R.

Ann Rheum Dis. 2015 Jul;74(7):1467-73. doi: 10.1136/annrheumdis-2013-204822. Epub 2014 Mar 18.

PMID:
24641944
25.

Thyroid and bone: macrophage-derived TSH-β splice variant increases murine osteoblastogenesis.

Baliram R, Chow A, Huber AK, Collier L, Ali MR, Morshed SA, Latif R, Teixeira A, Merad M, Liu L, Sun L, Blair HC, Zaidi M, Davies TF.

Endocrinology. 2013 Dec;154(12):4919-26. doi: 10.1210/en.2012-2234. Epub 2013 Oct 18.

26.

Elaidate, an 18-carbon trans-monoenoic fatty acid, inhibits β-oxidation in human peripheral blood macrophages.

Zacherl JR, Mihalik SJ, Chace DH, Christensen TC, Robinson LJ, Blair HC.

J Cell Biochem. 2014 Jan;115(1):62-70. doi: 10.1002/jcb.24633.

PMID:
23904193
27.

RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease.

Lo Iacono N, Pangrazio A, Abinun M, Bredius R, Zecca M, Blair HC, Vezzoni P, Villa A, Sobacchi C.

Clin Dev Immunol. 2013;2013:412768. doi: 10.1155/2013/412768. Epub 2013 May 15. Review.

28.

A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation.

Tantikanlayaporn D, Robinson LJ, Suksamrarn A, Piyachaturawat P, Blair HC.

Phytomedicine. 2013 Jun 15;20(8-9):676-82. doi: 10.1016/j.phymed.2013.02.008. Epub 2013 Apr 1.

29.

DNA damage drives accelerated bone aging via an NF-κB-dependent mechanism.

Chen Q, Liu K, Robinson AR, Clauson CL, Blair HC, Robbins PD, Niedernhofer LJ, Ouyang H.

J Bone Miner Res. 2013 May;28(5):1214-28. doi: 10.1002/jbmr.1851.

30.

Na+/H+ exchanger regulatory factor 1 (NHERF1) directly regulates osteogenesis.

Liu L, Alonso V, Guo L, Tourkova I, Henderson SE, Almarza AJ, Friedman PA, Blair HC.

J Biol Chem. 2012 Dec 21;287(52):43312-21. doi: 10.1074/jbc.M112.422766. Epub 2012 Oct 29.

31.

Vitamin C prevents hypogonadal bone loss.

Zhu LL, Cao J, Sun M, Yuen T, Zhou R, Li J, Peng Y, Moonga SS, Guo L, Mechanick JI, Iqbal J, Peng L, Blair HC, Bian Z, Zaidi M.

PLoS One. 2012;7(10):e47058. doi: 10.1371/journal.pone.0047058. Epub 2012 Oct 8.

32.

NHERF1 regulation of PTH-dependent bimodal Pi transport in osteoblasts.

Wang B, Yang Y, Liu L, Blair HC, Friedman PA.

Bone. 2013 Jan;52(1):268-77. doi: 10.1016/j.bone.2012.10.001. Epub 2012 Oct 7.

33.

Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling.

Baliram R, Sun L, Cao J, Li J, Latif R, Huber AK, Yuen T, Blair HC, Zaidi M, Davies TF.

J Clin Invest. 2012 Oct;122(10):3737-41. doi: 10.1172/JCI63948. Epub 2012 Sep 17.

34.

Osteopetrosis rescue upon RANKL administration to Rankl(-/-) mice: a new therapy for human RANKL-dependent ARO.

Lo Iacono N, Blair HC, Poliani PL, Marrella V, Ficara F, Cassani B, Facchetti F, Fontana E, Guerrini MM, Traggiai E, Schena F, Paulis M, Mantero S, Inforzato A, Valaperta S, Pangrazio A, Crisafulli L, Maina V, Kostenuik P, Vezzoni P, Villa A, Sobacchi C.

J Bone Miner Res. 2012 Dec;27(12):2501-10. doi: 10.1002/jbmr.1712.

35.

Blocking FSH action attenuates osteoclastogenesis.

Zhu LL, Tourkova I, Yuen T, Robinson LJ, Bian Z, Zaidi M, Blair HC.

Biochem Biophys Res Commun. 2012 May 25;422(1):54-8. doi: 10.1016/j.bbrc.2012.04.104. Epub 2012 Apr 27.

36.

Gene disruption of the calcium channel Orai1 results in inhibition of osteoclast and osteoblast differentiation and impairs skeletal development.

Robinson LJ, Mancarella S, Songsawad D, Tourkova IL, Barnett JB, Gill DL, Soboloff J, Blair HC.

Lab Invest. 2012 Jul;92(7):1071-83. doi: 10.1038/labinvest.2012.72. Epub 2012 Apr 30.

37.

Special stem cells for bone.

Zaidi M, Sun L, Blair HC.

Cell Stem Cell. 2012 Mar 2;10(3):233-4. doi: 10.1016/j.stem.2012.02.012.

38.

Further evidence that FSH causes bone loss independently of low estrogen.

Iqbal J, Blair HC, Zallone A, Sun L, Zaidi M.

Endocrine. 2012 Apr;41(2):171-5. doi: 10.1007/s12020-012-9626-y. Epub 2012 Feb 21. No abstract available.

PMID:
22350658
39.

Skeletal receptors for steroid-family regulating glycoprotein hormones: A multilevel, integrated physiological control system.

Blair HC, Robinson LJ, Sun L, Isales C, Davies TF, Zaidi M.

Ann N Y Acad Sci. 2011 Dec;1240:26-31. doi: 10.1111/j.1749-6632.2011.06287.x. Review.

PMID:
22172036
40.

Calcium and bone disease.

Blair HC, Robinson LJ, Huang CL, Sun L, Friedman PA, Schlesinger PH, Zaidi M.

Biofactors. 2011 May-Jun;37(3):159-67. doi: 10.1002/biof.143. Epub 2011 Jun 14. Review.

41.

High capacity Na+/H+ exchange activity in mineralizing osteoblasts.

Liu L, Schlesinger PH, Slack NM, Friedman PA, Blair HC.

J Cell Physiol. 2011 Jun;226(6):1702-12. doi: 10.1002/jcp.22501.

42.

Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage.

Mistry PK, Liu J, Yang M, Nottoli T, McGrath J, Jain D, Zhang K, Keutzer J, Chuang WL, Mehal WZ, Zhao H, Lin A, Mane S, Liu X, Peng YZ, Li JH, Agrawal M, Zhu LL, Blair HC, Robinson LJ, Iqbal J, Sun L, Zaidi M.

Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19473-8. doi: 10.1073/pnas.1003308107. Epub 2010 Oct 20. Erratum in: Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9220. Chuang, Wei-Lein [corrected to Chuang, Wei-Lien].

43.

The role of calcium release activated calcium channels in osteoclast differentiation.

Zhou Y, Lewis TL, Robinson LJ, Brundage KM, Schafer R, Martin KH, Blair HC, Soboloff J, Barnett JB.

J Cell Physiol. 2011 Apr;226(4):1082-1089. doi: 10.1002/jcp.22423.

44.

ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo.

Ishizuka H, García-Palacios V, Lu G, Subler MA, Zhang H, Boykin CS, Choi SJ, Zhao L, Patrene K, Galson DL, Blair HC, Hadi TM, Windle JJ, Kurihara N, Roodman GD.

J Bone Miner Res. 2011 Jan;26(1):169-81. doi: 10.1002/jbmr.199.

45.

Functional osteoclast attachment requires inositol-1,4,5-trisphosphate receptor-associated cGMP-dependent kinase substrate.

Yaroslavskiy BB, Turkova I, Wang Y, Robinson LJ, Blair HC.

Lab Invest. 2010 Oct;90(10):1533-42. doi: 10.1038/labinvest.2010.120. Epub 2010 Jun 21.

46.

Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis.

Wilson DC, Marinov AD, Blair HC, Bushnell DS, Thompson SD, Chaly Y, Hirsch R.

Arthritis Rheum. 2010 Aug;62(8):2510-6. doi: 10.1002/art.27485.

47.

ACTH protects against glucocorticoid-induced osteonecrosis of bone.

Zaidi M, Sun L, Robinson LJ, Tourkova IL, Liu L, Wang Y, Zhu LL, Liu X, Li J, Peng Y, Yang G, Shi X, Levine A, Iqbal J, Yaroslavskiy BB, Isales C, Blair HC.

Proc Natl Acad Sci U S A. 2010 May 11;107(19):8782-7. doi: 10.1073/pnas.0912176107. Epub 2010 Apr 26.

48.

Regulation of bone turnover by calcium-regulated calcium channels.

Robinson LJ, Blair HC, Barnett JB, Zaidi M, Huang CL.

Ann N Y Acad Sci. 2010 Mar;1192:351-7. doi: 10.1111/j.1749-6632.2009.05219.x. Review.

PMID:
20392259
49.

ACTH is a novel regulator of bone mass.

Isales CM, Zaidi M, Blair HC.

Ann N Y Acad Sci. 2010 Mar;1192:110-6. doi: 10.1111/j.1749-6632.2009.05231.x. Review.

PMID:
20392225
50.

Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis.

Romero G, Sneddon WB, Yang Y, Wheeler D, Blair HC, Friedman PA.

J Biol Chem. 2010 May 7;285(19):14756-63. doi: 10.1074/jbc.M110.102970. Epub 2010 Mar 8.

Supplemental Content

Loading ...
Support Center